SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced the following senior management appointments:
•James A. Nash, Senior Vice President, Technology Development and Operations
Help employers find you! Check out all the jobs and post your resume.
